亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

High specificity and sensitivity of NRAS Q61R immunohistochemistry (IHC) in melanomas

神经母细胞瘤RAS病毒癌基因同源物 免疫组织化学 医学 黑色素瘤 癌症 肿瘤科 癌症研究 病理 内科学 结直肠癌 克拉斯
作者
Pierre‐Alexandre Just,Christelle Pouliquen,Anne Audebourg,Sara Laurent‐Roussel,A. Carlotti,N. Dupin,Marie‐Cécile Vacher‐Lavenu,Michel Vidaud,Benoît Terris,Éric Pasmant
出处
期刊:Journal of The American Academy of Dermatology [Elsevier BV]
卷期号:74 (3): 572-573 被引量:6
标识
DOI:10.1016/j.jaad.2015.11.011
摘要

To the Editor: BRAF and NRAS are the most frequently mutated genes in melanoma (40%-50% and 20% of cases, respectively).1Jakob J.A. Bassett Jr., R.L. Ng C.S. et al.NRAS mutation status is an independent prognostic factor in metastatic melanoma.Cancer. 2012; 118: 4014-4023Crossref PubMed Scopus (501) Google Scholar Determining BRAF and NRAS tumor status is mandatory for patient treatment with targeted therapies and is commonly achieved by DNA sequencing. Immunohistochemistry (IHC) has recently appeared as a reliable surrogate technique for molecular BRAF V600E mutation screening.2Just P.A. Audebourg A. Pasmant E. et al.Immunohistochemistry versus next-generation sequencing for the routine detection of BRAF V600E mutation in melanomas.Hum Pathol. 2014; 45: 1983-1984Abstract Full Text Full Text PDF PubMed Scopus (7) Google Scholar Ilie et al3Ilie M. Long-Mira E. Funck-Brentano E. et al.Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.J Am Acad Dermatol. 2015; 72: 786-793Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar in this journal, and others,4Massi D. Simi L. Sensi E. et al.Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma.Mod Pathol. 2015; 28: 487-497Crossref PubMed Scopus (50) Google Scholar reported that IHC had 100% specificity and sensitivity for detecting the most frequent NRAS mutation, Q61R. We aimed to confirm these results on a different IHC platform (Bond-III, Leica Biosystems, Nussloch, Germany) in a selected series of 70 stage-IV melanomas previously screened by targeted next-generation sequencing for presence of NRAS and BRAF mutations.2Just P.A. Audebourg A. Pasmant E. et al.Immunohistochemistry versus next-generation sequencing for the routine detection of BRAF V600E mutation in melanomas.Hum Pathol. 2014; 45: 1983-1984Abstract Full Text Full Text PDF PubMed Scopus (7) Google Scholar After antigen retrieval (100°C for 60 minutes + 12 minutes' cooling with ER2 solution), slides were incubated with the anti-NRAS Q61R antibody, clone SP174 (1:100 dilution, SpringBio Science, Pleasanton, CA) for 20 minutes at 37°C and revealed using the Bond Polymer Refine Red detection kit (Leica Biosystems). Of the 22 of 70 cases with NRAS Q61R mutation, all but 1 displayed a moderate to strong cytoplasmic staining in more than 80% of tumor cells (Fig 1). The 1 remaining case showed heterogenous staining, with strongly stained areas adjacent to faintly stained areas. Tumor cellularity was estimated at ∼80% for this case, whereas NRAS Q61R mutation allelic ratio was estimated at ∼25% using next-generation sequencing. Faintly stained areas may therefore represent a tumor subclone without NRAS Q61R mutation. The remaining 48 cases (10 NRAS Q61L, 9 NRAS Q61K, 2 NRAS Q61H, 13 BRAF V600E, 1 BRAF V600K, and 13 cases with no NRAS or BRAF mutation) showed no staining. We confirmed 100% specificity and sensitivity of IHC for the diagnosis of NRAS Q61R mutation in melanoma. We often noticed a moderate to strong staining in endothelial cells (Fig 1), not described in previous studies.3Ilie M. Long-Mira E. Funck-Brentano E. et al.Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.J Am Acad Dermatol. 2015; 72: 786-793Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 4Massi D. Simi L. Sensi E. et al.Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma.Mod Pathol. 2015; 28: 487-497Crossref PubMed Scopus (50) Google Scholar This endothelial staining might be due to cross-reactivity with endothelial or serum proteins. Of note, anti-BRAF V600E antibody has been previously shown to cross-react with axonemal dynein of ciliated cells.5Jones R.T. Abedalthagafi M.S. Brahmandam M. et al.Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia.Mod Pathol. 2015; 28: 596-606Crossref PubMed Scopus (44) Google Scholar We also noticed a dramatic loss of antigenicity when slides were cut several days before IHC was performed. We therefore highly recommend performing NRAS Q61R IHC on freshly cut slides. BRAF V600E and NRAS Q61R IHC are superior to sequencing in terms of cost, rapidity, and tissue sparing. Furthermore, IHC may be more relevant than molecular techniques in tumors with very low cellularity, or high clonal heterogeneity. A strong and diffuse staining is specifically associated with the presence of NRAS Q61R or BRAF V600E mutations and molecular validation may not be mandatory in such cases. However, quality assurance and certification programs of oncogenetic testing require procedures to control genotype and patient/result matching. In our hospital, both IHC and next-generation sequencing analysis are performed in parallel on each sample to confirm the genotype and to detect potential false results of either technique, as described by Massi et al4Massi D. Simi L. Sensi E. et al.Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma.Mod Pathol. 2015; 28: 487-497Crossref PubMed Scopus (50) Google Scholar for NRAS sequencing or by us for BRAF V600E IHC.2Just P.A. Audebourg A. Pasmant E. et al.Immunohistochemistry versus next-generation sequencing for the routine detection of BRAF V600E mutation in melanomas.Hum Pathol. 2014; 45: 1983-1984Abstract Full Text Full Text PDF PubMed Scopus (7) Google Scholar
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
笨笨完成签到,获得积分10
2秒前
vchen0621完成签到,获得积分0
7秒前
certe完成签到,获得积分10
9秒前
11秒前
vchen0621发布了新的文献求助10
14秒前
先玩了玉完成签到,获得积分10
17秒前
俞无声完成签到 ,获得积分10
19秒前
花凉发布了新的文献求助20
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
研友_VZG7GZ应助科研通管家采纳,获得10
1分钟前
1分钟前
尊敬夜南完成签到,获得积分10
1分钟前
Cathy完成签到 ,获得积分10
1分钟前
今天看文献了吗完成签到,获得积分10
1分钟前
张晓祁完成签到,获得积分10
2分钟前
yueying完成签到,获得积分10
2分钟前
2分钟前
Owen应助尊敬夜南采纳,获得10
2分钟前
花凉完成签到,获得积分10
3分钟前
花凉发布了新的文献求助20
3分钟前
Ava完成签到,获得积分10
3分钟前
liudy完成签到,获得积分10
3分钟前
Ava发布了新的文献求助50
3分钟前
吃了吃了完成签到,获得积分10
3分钟前
liudy发布了新的文献求助10
3分钟前
领导范儿应助科研通管家采纳,获得10
3分钟前
4分钟前
阿紫吖完成签到 ,获得积分10
4分钟前
过时的白曼完成签到,获得积分10
4分钟前
隐形曼青应助三叔采纳,获得10
4分钟前
4分钟前
陈苗发布了新的文献求助10
4分钟前
在水一方应助scholar丨崔采纳,获得10
5分钟前
不能随便完成签到,获得积分10
5分钟前
5分钟前
碧蓝香芦完成签到 ,获得积分10
5分钟前
scholar丨崔发布了新的文献求助10
5分钟前
5分钟前
5分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990031
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256334
捐赠科研通 3270943
什么是DOI,文献DOI怎么找? 1805146
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228